Cantitate/Preț
Produs
Total produse
Vezi coșul
Diagnostic and Therapeutic Advances in Hematologic Malignancies de Martin S. Tallman

Diagnostic and Therapeutic Advances in Hematologic Malignancies: Cancer Treatment and Research, cartea 99

Editat de Martin S. Tallman, Leo I. Gordon
en Limba Engleză Hardback – 31 dec 1998

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 210915 lei  6-8 săpt.
  Springer Us – 29 mai 2013 210915 lei  6-8 săpt.
Hardback (1) 211629 lei  6-8 săpt.
  Springer Us – 31 dec 1998 211629 lei  6-8 săpt.

Din seria Cancer Treatment and Research

  • 5% T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies
    Preț: 110303 lei
  • 5% HIV/AIDS-Associated Viral Oncogenesis
    Preț: 72632 lei
  • 5% Tumor Microenvironment
    Preț: 78758 lei
  • 5% Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies
    Preț: 103793 lei
  • 5% Cancer Drug Safety and Public Health Policy: A Changing Landscape
    Preț: 103264 lei
  • 5% Therapeutic Approaches in Cancer Treatment
    Preț: 104177 lei
  • 5% Targeting the DNA Damage Response for Cancer Therapy
    Preț: 91742 lei
  • 5% Threshold Decision-making in Clinical Medicine: With Practical Application to Hematology and Oncology
    Preț: 71902 lei
  • 5% Epigenetics in Oncology
    Preț: 92018 lei
  • 5% Nutrition and Dietary Interventions in Cancer
    Preț: 104088 lei
  • 5% Adrenal and Endocrine Tumors in Children: Adrenal Cortical Carcinoma and Multiple Endocrine Neoplasia
    Preț: 72119 lei
  • 15% Bayesian Methods in Reliability
    Preț: 70010 lei
  • 5% Lung Cancer 1
    Preț: 37038 lei
  • 5% Gynecologic Oncology
    Preț: 211684 lei
  • 5% Palliative Care and Rehabilitation of Cancer Patients
    Preț: 141408 lei
  • 5% Advances in Allogeneic Hematopoietic Stem Cell Transplantation
    Preț: 142416 lei
  • 5% HIV & HTLV-I Associated Malignancies
    Preț: 110669 lei
  • 5% Thoracic Oncology
    Preț: 129762 lei
  • 5% Cancer Chemoprevention
    Preț: 110322 lei
  • 5% Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium
    Preț: 109444 lei
  • 5% Liver-Directed Therapy for Primary and Metastatic Liver Tumors
    Preț: 109645 lei
  • 5% Biology and Management of Lung Cancer
    Preț: 141356 lei
  • 5% Non-Myeloablative Allogeneic Transplantation
    Preț: 72010 lei
  • 5% Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
    Preț: 70677 lei
  • 5% Clinically Relevant Resistance in Cancer Chemotherapy
    Preț: 73107 lei
  • 5% Biostatistical Applications in Cancer Research
    Preț: 141480 lei
  • 5% Head and Neck Cancer
    Preț: 110872 lei
  • 5% Signal Transduction in Cancer
    Preț: 109812 lei
  • 5% Kidney Cancer
    Preț: 109222 lei
  • 5% Angiogenesis in Brain Tumors
    Preț: 109956 lei
  • 5% The Biology of Skeletal Metastases
    Preț: 110633 lei
  • 5% Molecular Targeting and Signal Transduction
    Preț: 109681 lei

Preț: 211629 lei

Preț vechi: 222767 lei
-5% Nou

Puncte Express: 3174
Preț estimativ în valută:
40499€ • 42026$ • 33851£

Carte tipărită la comandă

Livrare economică 17-31 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792382065
ISBN-10: 0792382064
Pagini: 377
Ilustrații: XIII, 377 p.
Dimensiuni: 155 x 233 x 22 mm
Greutate: 0.73 kg
Ediția:1999
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

New classifications for non-Hodgkin’s lymphoma.- Epstein—Barr virus and lymphoma.- Therapy of diffuse aggressive lymphomas.- The molecular biology of acute promyelocytic leukemia.- Current approaches to acute promyelocytic leukemia.- Prognosis in multiple myeloma.- Bone marrow and stem cell transplantation for multiple myeloma.- Hematopoietic growth factors and acute leukemia.- Novel treatment approaches for cutaneous T-cell lymphoma.- AIDS-associated lymphoma.- Mechanisms of resistance against B-cell malignancies induced by vaccination against the immunoglobulin receptor: the case for T-cell immunity.- Novel biologic approaches to hematologic malignancies.- Recent advances in the biology and management of acute lymphoblastic leukemia in adults.- Advances in the therapy of the myelodysplastic syndromes.